{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:40:58Z","timestamp":1777502458813,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejphar.2011.01.043","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T09:23:05Z","timestamp":1296897785000},"page":"81-87","source":"Crossref","is-referenced-by-count":17,"title":["Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5\/6 nephrectomized rat aorta"],"prefix":"10.1016","volume":"656","author":[{"given":"Hiroe","family":"Toba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisa","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.01.043_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10557-008-6111-1","article-title":"Use of erythropoietin for cardiovascular protection","volume":"22","author":"Bahlmann","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0010","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/ndt\/13.9.2210","article-title":"The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model","volume":"13","author":"Bellizzi","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cardiores.2006.06.026","article-title":"Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase","volume":"72","author":"Burger","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0030","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000127954.98131.23","article-title":"Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia\/reperfusion injury","volume":"109","author":"Cai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0035","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0040","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0140-6736(05)66622-6","article-title":"Pleiotropic renal actions of erythropoietin","volume":"365","author":"Chatterjee","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0934-8832(11)80070-3","article-title":"Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption","volume":"13","author":"Chen","year":"1993","journal-title":"Matrix"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2009.02.002","article-title":"Nitric oxide treatment reduces neo-intimal formation and modulates osteopontin expression in an ex-vivo human model of intimal hyperplasia","volume":"46","author":"Colotti","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cardfail.2009.05.010","volume":"15","author":"Comin-Colet","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1076\/apab.108.5.415.4298","article-title":"Effect of oral l-arginine administration for three weeks in two kidney\u2013two clip hypertensive rats","volume":"108","author":"de la Riva","year":"2000","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0065","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","article-title":"Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival","volume":"107","author":"Denhardt","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0955-0674(98)80149-X","article-title":"Mechanisms and consequences of activation of protein kinase B\/Akt","volume":"10","author":"Downward","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0075","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.106.085704","article-title":"Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin","volume":"49","author":"d'Uscio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0090","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.ATV.0000255560.49503.4e","article-title":"Association between osteopontin and human abdominal aortic aneurysm","volume":"27","author":"Golledge","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1523-1755.2002.00166.x","article-title":"Endothelial dysfunction and hypertension in 5\/6 nephrectomized rats are mediated by vascular superoxide","volume":"61","author":"Hasdan","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0110","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1172\/JCI116901","article-title":"Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta","volume":"92","author":"Ikeda","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2169\/internalmedicine.43.649","article-title":"Molecular biology of erythropoietin","volume":"43","author":"Jelkmann","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0120","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/j.1523-1755.2005.00331.x","article-title":"Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats","volume":"67","author":"Kohler","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.74.2.214","article-title":"Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro","volume":"74","author":"Liaw","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0130","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2006.08.031","article-title":"Protective effects of erythropoietin in cardiac ischemia: from bench to bedside","volume":"48","author":"Lipsic","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes","volume":"3","author":"Lund","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0140","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"Means","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0145","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/S0021-9258(19)63387-9","article-title":"Purification of human erythropoietin","volume":"252","author":"Miyake","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/15.8.1194","article-title":"Impaired endothelium-dependent vasodilatation in uraemia","volume":"15","author":"Morris","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1046\/j.1523-1755.2001.0600031077.x","article-title":"Impaired endothelial function in isolated human uremic resistance arteries","volume":"60","author":"Morris","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0165","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.14.10.1648","article-title":"Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques","volume":"14","author":"O'Brien","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7150\/ijbs.4.161","article-title":"The role of erythropoietin as an inhibitor of tissue ischemia","volume":"4","author":"Paschos","year":"2008","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.ASN.0000115398.92270.30","article-title":"Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences","volume":"15","author":"Ritz","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.V261053","article-title":"Cardiovascular complications in renal failure","volume":"2","author":"Rostand","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1537-1891(02)00250-1","article-title":"Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis","volume":"38","author":"Russo","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0195","doi-asserted-by":"crossref","first-page":"H781","DOI":"10.1152\/ajpheart.00045.2006","article-title":"In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries","volume":"291","author":"Santhanam","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0200","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0205","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0210","doi-asserted-by":"crossref","first-page":"p13","DOI":"10.1159\/000084657","article-title":"Protective effect of l-arginine intake on the impaired renal vascular responses in the gentamicin-treated rats","volume":"100","author":"Secilmis","year":"2005","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0215","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.01.043_bb0220","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2006040367","article-title":"Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease","volume":"18","author":"Tatematsu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2009.03.065","article-title":"Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat","volume":"612","author":"Toba","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0235","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejheart.2007.01.004","article-title":"Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial","volume":"9","author":"van Veldhuisen","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2011.01.043_bb0240","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12325-008-0055-5","article-title":"Erythropoietin reduces lipopolysaccharide-induced cell damage and midkine secretion in U937 human histiocytic lymphoma cells","volume":"25","author":"Yazihan","year":"2008","journal-title":"Adv. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T11:30:16Z","timestamp":1740915016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0014299911001014"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.01.043","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}